Pubblicazioni
scientifiche

I nostri ricercatori contribuiscono al progresso della conoscenza scientifica attraverso pubblicazioni realizzate insieme ai centri e alle università con cui collaboriamo in tutto il mondo.

ACS Omega novembre 2018

1,3-Dibromo-1,1-difluoro-2-propanone as a Useful Synthon for a Chemoselective Preparation of 4-Bromodifluoromethyl Thiazoles

M Colella et al.

Int J Paediatr Dent ottobre 2018

Efficacy of ketoprofen lysine salt and paracetamol/acetaminophen to reduce pain during rapid maxillary expansion: A randomized controlled clinical trial

G. Cossellu, V. Lanteri, R. Lione, A. Ugolini, F. Gaffuri, P. Cozza, M. Farronato

Ophthalmology settembre 2018

Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis

S. Bonini et al.

Ophthalmology settembre 2018

Phase I Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis

Bonini et al.

JCI Insight agosto 2018

IL-6 and CXCL8 Mediate Osteosarcoma-Lung Interactions Critical to Metastasis

AC Gross et al.

British journal of pharmacology maggio 2018

Antinociceptive Effect of Two Novel Transient Receptor Potential Melastatin 8 Antagonists in Acute and Chronic Pain Models in Rat

C De Caro et al.

British journal of pharmacology maggio 2018

Antinociceptive effect of two novel transient receptor potential melastatin 8 antagonists in acute and chronic pain models in rat

De Caro C et al.

European journal of medicinal chemistry aprile 2018

Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors

La Pietra V et al.

Molecular Cancer Therapeutics aprile 2018

Differential alteration of IL-8 in liver cancer stem cell enrichment in response to PI3K/Akt/mTOR inhibitors and sorafenib

Kahraman DC et al.

European Journal of immunology marzo 2018

CXCR2 Is Critical for Bacterial Control and Development of Joint Damage and Pain in Staphylococcus Aureus-Induced Septic Arthritis in Mouse

D Boff et al. Eur J Immunol

Pubblicazioni per autore: 57
Citazioni: 1699
H-index (2015-2016): 39.5
H-index (2017-2018): 42.4
H-index (2019-2020): 51.5

Rapporto tra numero documenti e citazioni

Fonte: Elsevier Scopus

Numero ponderato di pubblicazioni per area tematica

Fonte: Elsevier Scopus

Dompé farmaceutici S.p.A. Socio Unico / Capitale sociale € 50.000.000,00
REA MI 289519 - Registro Imprese di Milano / Codice Fiscale e Partita IVA (VAT) IT00791570153